---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-085391"
form_type: "8-K"
ticker: "BNBX"
cik: "0000744452"
company_name: "BNB PLUS CORP."
filed_at: "2024-08-02T23:59:59+00:00"
generated_at: "2026-05-31T13:32:57.443897+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.5
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Applied DNA Sciences special meeting fails due to lack of quorum; warrant approval deferred

## Summary
- Special meeting on Aug 2, 2024 had 4,056,202 shares present, below required majority; adjourned without action.
- Proposal sought stockholder approval to exercise Series A and B warrants from May 2024 public offering.
- Without approval, company must call a subsequent meeting to seek warrant stockholder approval.
- Series Warrants remain unexercisable until Nasdaq-required shareholder approval is obtained.

## SEC filing metadata
- accession: 0001104659-24-085391
- form_type: 8-K
- ticker: BNBX
- cik: 0000744452
- company_name: BNB PLUS CORP.
- filed_at: 2024-08-02T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.5
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/744452/000110465924085391/0001104659-24-085391-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/744452/000110465924085391/tm2420716d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-085391
- JSON: https://secwatch.observer/filing/0001104659-24-085391.json
- Plain text: https://secwatch.observer/filing/0001104659-24-085391.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.